Dr. Ira Stephen Blaufarb, MD

Dr. Blaufarb practices at Cardio Vascular Institute of Mount Sinai in New York, New York.

Dr. Blaufarb's NPI, 1154335842, was assigned on July 28, 2006. Dr. Blaufarb graduated from Sidney Kimmel Medical College in 1991. Dr. Blaufarb's New York license number on file is 192074.

Dr. Blaufarb's primary practice is Cardio Vascular Institute of Mount Sinai, at 177 E 87th St, New York, NY 10128 in New York County. The practice phone is (212) 731-7822.

Dr. Blaufarb's primary practice is Cardio Vascular Institute of Mount Sinai in New York, New York. Dr. Blaufarb is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Blaufarb to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blaufarb practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Blaufarb's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Blaufarb is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Blaufarb has a license on file in New York.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Blaufarb treats.

CMS data shows 5,179 Medicare services from Dr. Blaufarb across 23 procedure codes in 2024, for 1,025 Medicare patients. Medicare paid $340,702 for them.

CMS counts 1,025 Medicare patients who saw Dr. Blaufarb in 2024. The largest group is 75 to 84, with 449 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Blaufarb's median patient age at 70, with 47% women.

In 2024, Dr. Blaufarb wrote 6,785 Medicare Part D claims for 833 patients. 81% of them were for generic drugs. CMS names the drug for 6,410 of them, across 66 drugs with 11 or more claims each, at $1,301,612 in total drug cost. In 2023, CMS named 5,981 claims across 64 drugs.

Dr. Blaufarb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blaufarb as offering telehealth.

Dmand AI links 5 papers to Dr. Blaufarb in 2015. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists and Double-Blind Method. Dr. Blaufarb's most frequent co-authors are Glenn S. Hamroff, MD, Darwin D. Chen, MD and David Alexander Forsh, MD.

CMS Open Payments shows 14 general payments to Dr. Blaufarb from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Boston Scientific Corporation paid the most, $145.

Dmand AI lists 3 awards for Dr. Blaufarb, most recently ACC Fellow in 2012.

Dr. Blaufarb graduated from Sidney Kimmel Medical College in 1991. Dr. Blaufarb is a member of ACC.

Dr. Blaufarb is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.